Riociguat for the Treatment of Pulmonary Arterial Hypertension von Ghofrani, Hossein-Ardeschir, Galiè, Nazzareno, Grimminger, Friedrich, Grünig, Ekkehard, Humbert, Marc, Jing, Zhi-Cheng, Keogh, Anne M, Langleben, David, Kilama, Michael Ochan, Fritsch, Arno, Neuser, Dieter, Rubin, Lewis J

Volltext

Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer von Wakelee, Heather, Liberman, Moishe, Kato, Terufumi, Tsuboi, Masahiro, Lee, Se-Hoon, Gao, Shugeng, Chen, Ke-Neng, Dooms, Christophe, Majem, Margarita, Eigendorff, Ekkehard, Martinengo, Gastón L., Bylicki, Olivier, Rodríguez-Abreu, Delvys, Chaft, Jamie E., Novello, Silvia, Yang, Jing, Keller, Steven M., Samkari, Ayman, Spicer, Jonathan D.

Volltext

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension von Hoeper, Marius M., Badesch, David B., Ghofrani, H. Ardeschir, Gibbs, J. Simon R., Gomberg-Maitland, Mardi, McLaughlin, Vallerie V., Preston, Ioana R., Souza, Rogerio, Waxman, Aaron B., Grünig, Ekkehard, Kopeć, Grzegorz, Meyer, Gisela, Olsson, Karen M., Rosenkranz, Stephan, Xu, Yayun, Miller, Barry, Fowler, Marcie, Butler, John, Koglin, Joerg, de Oliveira Pena, Janethe, Humbert, Marc

Volltext

Selexipag for the Treatment of Pulmonary Arterial Hypertension von Sitbon, Olivier, Channick, Richard, Chin, Kelly M, Frey, Aline, Gaine, Sean, Galiè, Nazzareno, Ghofrani, Hossein-Ardeschir, Hoeper, Marius M, Lang, Irene M, Preiss, Ralph, Rubin, Lewis J, Di Scala, Lilla, Tapson, Victor, Adzerikho, Igor, Liu, Jinming, Moiseeva, Olga, Zeng, Xiaofeng, Simonneau, Gérald, McLaughlin, Vallerie V

Volltext

Tadalafil Therapy for Pulmonary Arterial Hypertension von GALIE, Nazzareno, BRUNDAGE, Bruce H, FRUMKIN, Lyn, BARST, Robyn J, GHOFRANI, Hossein A, OUDIZ, Ronald J, SIMONNEAU, Gerald, SAFDAR, Zeenat, SHAPIRO, Shelley, WHITE, R. James, CHAN, Melanie, BEARDSWORTH, Anthony

Volltext

Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomi... von Hoeper, Marius M, Al-Hiti, Hikmet, Benza, Raymond L, Chang, Sung-A, Corris, Paul A, Gibbs, J Simon R, Grünig, Ekkehard, Jansa, Pavel, Klinger, James R, Langleben, David, McLaughlin, Vallerie V, Meyer, Gisela M B, Ota-Arakaki, Jaquelina, Pulido, Tomás, Rosenkranz, Stephan, Vizza, Carmine Dario, Vonk-Noordegraaf, Anton, White, R James, Chang, Mikyung, Meier, Christian, Paraschin, Karen, Ghofrani, Hossein Ardeschir, Simonneau, Gérald, Olschewski, H, Delcroix, M, Andrade-Lima, M, de Amorim Corrêac, R, Meyer, G, De Souza, R, Al-Hiti, H, Jansa, P, Mellemkjær, S, Bauer, F, Montani, D, Simonneau, G, Drömann, D, Ghofrani, H-A, Grünig, E, Halank, M, Held, M, Hoeper, MM, Klose, H, Kneidinger, N, Leuchte, H, Opitz, C, Rosenkranz, S, Wirtz, H, Karvounis, H, Pitsiou, G, Orfanos, S, D'Alto, M, Ghio, S, Vitulo, P, Maki, H, Tatebe, S, de los Rios Ibarra, M, Pulido, T, Van Dijk, A, Vonk-Noordegraaf, A, Roleder, T, Castro, G, Loureiro, MJ, Robalo-Martins, S, Barberá, JA, Lázaro, M, Perez-Penate, GM, Román, A, Cheng, C-C, Hsu, H-H, Atahan, E, Mogulkoc Bishop, N, Okumus, NG, Onen, Z, Chang, H-J, Chang, S-A, Lee, J-S, Kim, H-K, Coghlan, JG, Corris, PA, Church, AC, Gibbs, JSR, Peacock, AJ, Wort, S, Allen, S, Awdish, R, Benza, RL, DeSouza, S, Feldman, J, Johri, S, Klinger, JR, Layish, D, McConnell, J, McLaughlin, VV, Migliore, C, Rahaghi, F, Rischard, F, Robbins, I, Satterwhite, L, Sulica, R, White, RJ

Volltext

Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAH von Eichstaedt, Christina A, Belge, Catharina, Chung, Wendy K, Gräf, Stefan, Grünig, Ekkehard, Montani, David, Quarck, Rozenn, Tenorio-Castano, Jair A, Soubrier, Florent, Trembath, Richard C, Morrell, Nicholas W

Volltext

Randomized Study of CODE Versus Alternating CAV/EP for Extensive-Stage Small-Cell Lung Cancer: An Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group... von MURRAY, N, LIVINGSTON, R. B, TURRISI, A, WALDE, D, CROFT, H, OSOBA, D, OTTAWAY, J, GANDARA, D, SHEPHERD, F. A, JAMES, K, ZEE, B, LANGLEBEN, A, KRAUT, M, BEARDEN, J, GOODWIN, J. W, GRAFTON, C

Volltext

Defining the clinical validity of genes reported to cause pulmonary arterial hypertension von Welch, Carrie L., Aldred, Micheala A., Balachandar, Srimmitha, Dooijes, Dennis, Eichstaedt, Christina A., Gräf, Stefan, Houweling, Arjan C., Machado, Rajiv D., Pandya, Divya, Prapa, Matina, Shaukat, Memoona, Southgate, Laura, Tenorio-Castano, Jair, Callejo, Emily P., Day, Kristina M., Macaya, Daniela, Maldonado-Velez, Gabriel, Chung, Wendy K., Archer, Stephen L., Auckland, Kathryn, Austin, Eric D., Badagliacca, Roberto, Barberà, Joan-Albert, Belge, Catharina, Bogaard, Harm Jan, Bonnet, Sébastien, Boomars, Karin A., Boucherat, Olivier, Chakinala, Murali M., Condliffe, Robin, Damico, Rachel Lynn, Delcroix, Marion, Desai, Ankit A., Doboszynska, Anna, Elliott, C. Greg, Eyries, Melanie, Escribano Subías, Maria Pilar, Gall, Henning, Ghio, Stefano, Ghofrani, Ardeschir-Hossein, Grünig, Ekkehard, Hamid, Rizwan, Harbaum, Lars, Hassoun, Paul M., Hemnes, Anna R., Hinderhofer, Katrin, Howard, Luke S., Humbert, Marc, Kiely, David G., Langleben, David, Lawrie, Allan, Loyd, Jim E., Moledina, Shahin, Montani, David, Morrell, Nichols W., Nichols, William C., Olschewski, Andrea, Olschewski, Horst, Papa, Silvia, Pauciulo, Mike W., Provencher, Steve, Quarck, Rozenn, Rhodes, Christopher J., Scelsi, Laura, Seeger, Werner, Stewart, Duncan J., Sweatt, Andrew, Swietlik, Emilia M., Treacy, Carmen, Trembath, Richard C., Tura-Ceide, Olga, Vizza, Carmine Dario, Vonk Noordegraaf, Anton, Wilkins, Martin R., Zamanian, Roham T., Zateyshchikov, Dmitry

Volltext

Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: A placebo-controlled trial von Hiremath, Jagdish, MD, Thanikachalam, Sadagopa, MD, Parikh, Keyur, MD, Shanmugasundaram, Somasundaram, MD, Bangera, Sudhakar, MD, Shapiro, Leland, MD, Pott, Gregory B., PhD, Vnencak-Jones, Cindy L., PhD, Arneson, Carl, MStat, Wade, Michael, PhD, White, R. James, MD, PhD

Volltext

Prophylactic Cranial Irradiation in Advanced Breast Cancer: Long-Term Results From a Trial of High-Dose Epirubicin and Tandem Autologous Bone Marrow Transplantation von Huang, F, Al Refae, M, Langleben, A, Roberge, D

Volltext

MA11.07 Pembrolizumab Plus Maintenance Olaparib as First-Line Therapy for Metastatic Nonsquamous NSCLC: Phase 3 KEYLYNK-006 Study von Gray, J., Schenker, M., Sendur, M.A.N., Kim, S.-W., Leonova, V., Kowalski, D., Kato, T., Orlova, R., Yang, J.C.-H., Langleben, A., Breyer, M.-K., Ungureanu, A., Perez Mak, M., De Angelis, F., Zimmer, Z., Zhao, B., Shamoun, M., Kim, T.M.

Volltext

Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer von CRAWFORD, J, O'ROURKE, J. H, WHITE, R, HOHNEKER, J, SPIRIDONITIS, C. H, YANOVICH, S, OZER, H, LANGLEBEN, A, HUTCHINS, L.L, KOLETSKY, A, CLAMAN, G, BURMAN, S

Volltext

A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer von Hoff, P M, Kopetz, S, Thomas, M B, Langleben, A, Rinaldi, D, Anthony, L, Wolff, R A, Lassere, Y, Abbruzzese, J L

Volltext

6MO Pembrolizumab plus ipilimumab or placebo in previously untreated metastatic NSCLC with PD-L1 tumor proportion score ≥50%: KEYNOTE-598 3-year follow-up von Rodriguez Abreu, D., Reck, M., Şendur, N., Park, K., Lee, D.H., Cicin, I., Yumuk, P.F., Orlandi, F.J., Leal, T.A., Soparattanapaisarn, N., Langleben, A., Califano, R., Medgyasszay, B., Hsia, T-C., Otterson, G.A., Woods, T., Jensen, E., Samkari, A., Boyer, M.

Volltext

Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension von Barst, Robyn J., MD, Oudiz, Ronald J., MD, Beardsworth, Anthony, MD, Brundage, Bruce H, Simonneau, Gerald, MD, Ghofrani, Hossein A., MD, Sundin, David P., PhD, Galiè, Nazzareno, MD

Volltext

EP05.02-019 Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Surgical Outcomes in a Regionalized Pulmonary Oncology Network von Pilon, Y., Rokah, M., Rayes, R.F., Cools-Lartigue, J., Najmeh, S., Sirois, C., Mulder, D., Ferri, L., Abdulkarim, B., Ezer, N., Fraser, R., Camilleri-Broët, S., Fiset, P.-O., Wong, A., Sud, S., Langleben, A., Agulnik, J., Pepe, C., Shieh, B., Hirsh, V., Ofiara, L., Owen, S., Spicer, J.D.

Volltext

PS01.09 Pembrolizumab Plus Ipilimumab vs Pembrolizumab Plus Placebo as 1L Therapy for Metastatic NSCLC of PD-L1 TPS ≥50%: KEYNOTE-598 von Boyer, M., Sendur, M.A.N., Rodríguez-Abreu, D., Park, K., Lee, D.H., Cicin, I., Yumuk, P.F., Orlandi, F., Leal, T., Molinier, O., Soparattanapaisam, N., Langleben, A., Califano, R., Medgyasszay, B., Hsia, T., Otterson, G., Xu, L., Piperdi, B., Samkari, A., Reck, M.

Volltext

Docetaxel and Gemcitabine administered on days 1 and 8 for metastatic non-small cell lung carcinoma (NSCLC): a phase II multicenter trial von Hirsh, Vera, Whittom, R., Desjardins, P., Laberge, F., Latreille, J., Samson, B., Langleben, A.

Volltext

Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III st... von MILLER, A. A, HERNDON, J. E, HOLLIS, D. R, ELLERTON, J, LANGLEBEN, A, RICHARDS, F. II, GREEN, M. R

Volltext